CN
  • Home
  • About Us
  • News
  • R&D innovation

    Back

    Biopharmaceuticals
    Functional ingredients
    Nutritional products
  • Product Center

    Back

    Biopharmaceuticals
    Functional ingredients
    Nutritional products
  • Internationalization
  • Development
Back
2023/ 12/02

【媒体报道】超300%增长,今年最强医药股凭什么?

20231204180515_86763.png

< Previous Article:巨石生物签署关于登革热mRNA疫苗研发协议 Next Article:石药创新新冠病毒二价mRNA疫苗被纳入紧急使用

Related News

  • 2026/05/11
    2026 AACR: SYS6010 Nasopharyngeal Carcinoma Research Results Released by CSPC Innovation
  • 2026/04/28
    Five innovative drug research achievements of CSPC Innovation have been selected for the
  • 2025/11/18
    CSPC Innovative Presents Omalizumab for Injection at 2025 National Congress of Aesthetic Dermatology
  • 2025/11/11
    CSPC Innovation Successfully Passes BRCGS Certification
News
About Us Contact Us Site Map Legal terms

Phone: 0311-85408700

Address:No. 62 Zhangju Road, Luancheng District, Shijiazhuang City, Hebei Province

©2024 CSPC INNOVATION PHARMACEUTICAL CO., LTD. 冀ICP备05003393号-7 PowerBy XinHongRu